Natera, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$330.4M
89 notices · 1,384,633 sh
Oct 2025 to Oct 2026
Reported ·
$276.0M
346 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
318 of 346 reported sales carry the 10b5-1 box. Together they are 0.89% of the shares on issue.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-10-01STEVEN L CHAPMAN, CEO AND PRESIDENT$526,144
2026-10-01SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$1,242,645
2026-09-23Sheena Jonathan, Director$8,163,402
2026-09-15TINKERBELLE II TR U/A DTD 10/22/2021, EXECUTIVE CHAIRMAN$700,015
2026-09-11MATTHEW RABINOWITZ, EXECUTIVE CHAIRMAN$65.2M
2026-09-02SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$0
2026-09-01STEVEN L CHAPMAN, CEO AND PRESIDENT$545,041
2026-09-01SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$962,194
2026-08-07TINKERBELLE II TR U/A DTD 10/22/2021, EXECUTIVE CHAIRMAN$641,800
2026-08-07Sheena Jonathan, Director$5,951,100
2026-08-04MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$129,232
2026-08-03JOHN FESKO, PRESIDENT, CHIEF BUS. OFFICER$78,186
2026-08-03SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$108,443
2026-08-03STEVEN L CHAPMAN, CEO AND PRESIDENT$502,668
2026-08-03SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$795,751
2026-08-03DANIEL RABINOWITZ, SEC. AND CHIEF LEGAL OFFICER$88,361
2026-08-03STEVEN CHAPMAN, CEO AND PRESIDENT$312,476
2026-08-03MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$83,809
2026-08-03JONATHAN SHEENA, OFFICER$28,918
2026-08-03MATTHEW RABINOWITZ, EXECUTIVE CHAIRMAN$193,323
2026-07-29MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$469,886
2026-07-28JOH N FESKO, PRESIDENT, CHIEF BUS. OFFICER$236,614
2026-07-28SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$305,766
2026-07-28MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$303,959
2026-07-28DANIEL RABINOWITZ, SEC. AND CHIEF LEGAL OFFICER$254,934
2026-07-28STEVEN CHAPMAN, CEO AND PRESIDENT$909,556
2026-07-28MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$315,313
2026-07-28JONATHAN SHEENA, DIRECTOR$48,510
2026-07-27JOHN FESKO, PRESIDENT, CHIEF BUS. OFFICER$202,256
2026-07-27SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$261,466
2026-07-27DANIEL RABINOWITZ, SEC. AND CHIEF LEGAL OFFICER$228,717
2026-07-27STEVEN CHAPMAN, CEO AND PRESIDENT$566,684
2026-07-27MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$202,256
2026-07-27JONATHAN SHEENA, DIRECTOR$74,667
2026-07-27MATTHEW RABINOWITZ, EXECUTIVE CHAIRMAN$444,597
2026-07-15ROWAN EMMA CHAPMAN, Director$37,101
2026-07-15Sheena Jonathan, Director$412,830
2026-07-13Sheena Jonathan, Director$2,515,779
2026-07-06TINKERBELLE II TR U/A DTD 10/22/2021, EXECUTIVE CHAIRMAN$280,000
2026-07-01DANIEL RABINOWITZ, SEC. AND CHIEF LEGAL OFFICER$4,560,360
2026-07-01SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$818,711
2026-06-24DANIEL RABINOWITZ, SEC. AND CHIEF LEGAL OFFICER$7,887,936
Form 4, 2026-06-26: sold 33,600 at $251.65 Form 4 ↗
2026-06-24HERMAN ROSENMAN, Director$4,132,500
Form 4, 2026-06-26: sold 16,530 at $250.00 Form 4 ↗
2026-06-16ROWAN EMMA CHAPMAN, Director$642,536
Form 4, 2026-06-17: sold 2,964 at $216.78 Form 4 ↗
2026-06-12MATTHEW RABINOWITZ, EXECUTIVE CHAIRMAN$21.9M
Form 4, 2026-06-16: sold 100,000 at $214.47 Form 4 ↗
2026-06-05GAIL MARCUS, Director$2,389,328
Form 4, 2026-06-09: sold 11,000 at $217.21 Form 4 ↗
2026-06-04STEVEN L CHAPMAN, CEO AND PRESIDENT$9,089,778
Form 4, 2026-06-05: sold 41,124 at $221.03 Form 4 ↗
2026-06-01BV369 TRUST, Affiliate$17.2M
Form 4, 2026-06-03: sold 78,000 at $220.31 Form 4 ↗
2026-06-01SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$655,295
Form 4, 2026-06-03: sold 3,000 at $218.43 Form 4 ↗
2026-05-04MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$99,909
2026-05-01SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$610,065
Form 4, 2026-05-05: sold 3,405 at $203.69 Form 4 ↗
2026-04-29MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$614,522
Form 4, 2026-05-05: sold 795 at $208.79 Form 4 ↗
2026-04-01SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$606,899
Form 4, 2026-04-03: sold 3,000 at $202.30 Form 4 ↗
2026-03-20Sheena Jonathan, Director$1,201,500
Form 4, 2026-04-21: sold 1,500 at $199.63 Form 4 ↗
2026-03-18Sheena Jonathan, Director$2,465,309
Form 4, 2026-03-20: sold 4,570 at $198.75 Form 4 ↗
2026-03-13ROWAN EMMA CHAPMAN, Director$23,348
Form 4, 2026-03-17: sold 122 at $191.38 Form 4 ↗
2026-03-12MATTHEW RABINOWITZ, EXECUTIVE CHAIRMAN$39.3M
Form 4, 2026-03-16: sold 200,000 at $191.42 Form 4 ↗
2026-03-06DANIEL RABINOWITZ, SEC. AND CHIEF LEGAL OFFICER$3,311,558
Form 4, 2026-03-10: sold 8,398 at $196.08 Form 4 ↗
2026-03-02STEVEN L CHAPMAN, CEO AND PRESIDENT$790,095
Form 4, 2026-03-03: sold 3,950 at $200.02 Form 4 ↗
2026-03-02SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$599,545
Form 4, 2026-03-03: sold 3,000 at $199.85 Form 4 ↗
2026-02-03MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$1,310,568
Form 4, 2026-02-04: sold 6,939 at $227.83 Form 4 ↗
2026-02-02STEVEN L CHAPMAN, CEO AND PRESIDENT$19.7M
Form 4, 2026-02-04: sold 90,024 at $230.72 Form 4 ↗
2026-02-02SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$694,309
Form 4, 2026-02-04: sold 4,639 at $231.20 Form 4 ↗
2026-01-29MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$440,481
2026-01-28MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$282,640
2026-01-21MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$8,589,169
Form 4, 2026-01-29: sold 5,064 at $235.38 Form 4 ↗
2026-01-02SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$675,621
Form 4, 2026-01-06: sold 2,951 at $228.95 Form 4 ↗
2026-01-02STEVEN L CHAPMAN, CEO AND PRESIDENT$881,482
Form 4, 2026-01-06: sold 3,848 at $229.08 Form 4 ↗
2025-12-19Sheena Jonathan, Director$990,000
Form 4, 2025-12-22: sold 1,500 at $225.94 Form 4 ↗
2025-12-17Sheena Jonathan, Director$2,099,880
Form 4, 2025-12-17: sold 3,070 at $227.01 Form 4 ↗
2025-12-12Herm Rosenman Trust, Board member$11.3M
Form 4, 2025-12-16: sold 48,419 at $227.42 Form 4 ↗
2025-12-12SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$1,082,714
Form 4, 2025-12-16: sold 4,692 at $230.76 Form 4 ↗
2025-12-05ROWAN EMMA CHAPMAN, Director$1,061,391
Form 4, 2025-12-09: sold 4,366 at $243.11 Form 4 ↗
2025-12-01STEVEN L CHAPMAN, CEO AND PRESIDENT$1,047,501
Form 4, 2025-12-03: sold 4,400 at $238.07 Form 4 ↗
2025-12-01SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$714,459
Form 4, 2025-12-03: sold 3,000 at $238.15 Form 4 ↗
2025-11-24BV369 TRUST, Affiliate$17.7M
Form 4, 2025-11-26: sold 75,000 at $236.12 Form 4 ↗
2025-11-20ROY BAYNES, Director$1,710,600
2025-11-20Sheena Jonathan, Director$2,250,186
Form 4, 2025-11-21: sold 14,000 at $226.49 Form 4 ↗
2025-11-19ROY BAYNES, Director$1,099,088
Form 4, 2025-11-21: sold 12,780 at $219.85 Form 4 ↗
2025-11-04MATTHEW RABINOWITZ, EXECUTIVE CHAIRMAN$4,539,467
Form 4, 2025-11-04: sold 22,900 at $200.51 Form 4 ↗
2025-11-03MATTHEW RABINOWITZ, EXECUTIVE CHAIRMAN$3,401,703
Form 4, 2025-11-03: sold 17,100 at $200.00 Form 4 ↗
2025-11-03SOLOMON MOSHKEVICH, PRESIDENT, CLINICALDIAGNOSTICS$595,810
Form 4, 2025-11-04: sold 3,000 at $198.60 Form 4 ↗
2025-11-03STEVEN L CHAPMAN, CEO AND PRESIDENT$32.1M
Form 4, 2025-11-03: sold 160,703 at $199.96 Form 4 ↗
2025-11-03Gail Marcus, Director$24,243
Form 4, 2025-11-04: sold 122 at $198.71 Form 4 ↗
2025-10-29MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$353,927
Form 4, 2026-01-22: sold 61,123 at $239.49 Form 4 ↗
2025-10-28MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$226,435
2025-10-24MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$147,225
Form 4, 2025-10-22: sold 602 at $187.95 Form 4 ↗
2025-10-22MICHAEL BROPHY, CHIEF FINANCIAL OFFICER$171,930
Form 4, 2025-10-24: sold 2,170 at $190.30 Form 4 ↗